The clinical pharmacokinetics of phenytoin.

Suppr

超能文献

作者信息

Martin E, Tozer T N, Sheiner L B, Riegelman S

出版信息

J Pharmacokinet Biopharm. 1977 Dec;5(6):579-96. doi: 10.1007/BF01059685.

DOI:10.1007/BF01059685

PMID:599408

Abstract

摘要

相似文献

The clinical pharmacokinetics of phenytoin.

J Pharmacokinet Biopharm. 1977 Dec;5(6):579-96. doi: 10.1007/BF01059685.

Use of stable isotopes in the study of pharmacokinetics of drugs by mass fragmentography II: Detailed examination of pharmacokinetics of a single oral dose of phenytoin in humans.

J Pharm Sci. 1980 Nov;69(11):1300-7. doi: 10.1002/jps.2600691118.

Failure of antacids to alter the pharmacokinetics of phenytoin.抗酸剂未能改变苯妥英的药代动力学。

Br J Clin Pharmacol. 1978 Aug;6(2):176-7. doi: 10.1111/j.1365-2125.1978.tb00847.x.

[Studies on clinical pharmacokinetics and bioavailability of sodium phenytoin by high performance liquid chromatography (HPLC)].[苯妥英钠的高效液相色谱法临床药代动力学及生物利用度研究]

Yao Xue Xue Bao. 1983 Jul;18(7):487-90.

Pharmacokinetics of a large single dose phenytoin.大剂量单次苯妥英的药代动力学

Taiwan Yi Xue Hui Za Zhi. 1983 Mar;82(3):370-80.

Bioavailability and single-dose pharmacokinetics of intramuscular phenytoin.苯妥英钠肌内注射的生物利用度及单剂量药代动力学

Clin Pharmacol Ther. 1975 Oct;18(4):449-56. doi: 10.1002/cpt1975184449.

Phenytoin pharmacokinetics: inappropriate data analysis.苯妥英钠的药代动力学：不恰当的数据分析。

Am J Hosp Pharm. 1982 Jan;39(1):41-3.

[Therapy service and pharmacokinetics of phenytoin].[苯妥英的治疗服务与药代动力学]

Padiatr Grenzgeb. 1978;17(2):69-81.

Phenytoin: pharmacokinetics and bioavailability.苯妥英钠：药代动力学与生物利用度。

Clin Pharmacol Ther. 1976 Feb;19(2):135-42. doi: 10.1002/cpt1976192135.

Clinical pharmacokinetics of sodium valproate, carbamazepine and phenytoin. Level-dose ration and interactions.丙戊酸钠、卡马西平和苯妥英钠的临床药代动力学。负荷剂量与维持剂量之比及相互作用。

Schweiz Rundsch Med Prax. 1984 Feb 7;73(6):159-63.

引用本文的文献

Thioacetalation and Multi-Component Thiomethylative Friedel-Crafts Arylation Using BFSMe.使用BFSMe进行硫缩醛化反应及多组分硫甲基化傅克芳基化反应。

ACS Omega. 2023 Jan 19;8(4):4320-4330. doi: 10.1021/acsomega.2c07608. eCollection 2023 Jan 31.

Phenytoin-associated movement disorder: A literature review.苯妥英钠相关运动障碍：文献综述

Tzu Chi Med J. 2022 Oct 3;34(4):409-417. doi: 10.4103/tcmj.tcmj_74_22. eCollection 2022 Oct-Dec.

'Tablet-in-Syringe': A Novel Dosing Mechanism for Dysphagic Patients Containing Fast-Disintegrating Tablets Fabricated Using Semisolid Extrusion 3D Printing.“注射器内片剂”：一种用于吞咽困难患者的新型给药机制，包含使用半固体挤出3D打印制造的速崩解片剂。

Pharmaceutics. 2022 Feb 18;14(2):443. doi: 10.3390/pharmaceutics14020443.

The perils of antiepileptic toxicity.抗癫痫药物毒性的危害。

Aust Prescr. 2020 Apr;43(2):61-63. doi: 10.18773/austprescr.2020.012. Epub 2020 Apr 1.

Nonlinear protein binding of phenytoin in clinical practice: Development and validation of a mechanistic prediction model.临床实践中苯妥英的非线性蛋白结合：机制预测模型的建立与验证。

Br J Clin Pharmacol. 2019 Oct;85(10):2360-2368. doi: 10.1111/bcp.14053. Epub 2019 Aug 7.

Correlation between measured and calculated free phenytoin serum concentration in neurointensive care patients with hypoalbuminemia.低白蛋白血症神经重症监护患者中游离苯妥英血清浓度测量值与计算值之间的相关性

Clin Pharmacol. 2018 Dec 13;10:183-190. doi: 10.2147/CPAA.S186322. eCollection 2018.

Development and Validation of an LC-MS/MS Method and Comparison with a GC-MS Method to Measure Phenytoin in Human Brain Dialysate, Blood, and Saliva.一种液相色谱-串联质谱法的开发与验证及其与气相色谱-质谱法在测定人脑透析液、血液和唾液中苯妥英的比较

J Anal Methods Chem. 2018 Apr 1;2018:8274131. doi: 10.1155/2018/8274131. eCollection 2018.

Concentration-related mydriasis in a patient with renal dysfunction treated with phenytoin.苯妥英治疗的肾功能不全患者出现的浓度相关性瞳孔散大。

Hippokratia. 2016 Apr-Jun;20(2):166-168.

Free phenytoin assessment in patients: measured versus calculated blood serum levels.患者游离苯妥英评估：实测血清水平与计算血清水平对比

Int J Clin Pharm. 2016 Apr;38(2):303-9. doi: 10.1007/s11096-015-0241-x. Epub 2016 Jan 8.

Fixed Drug Eruption in an Epileptic Patient Previously Receiving Treatment With Phenytoin for Seven Years.一名曾接受苯妥英钠治疗七年的癫痫患者发生固定性药疹。

J Investig Med High Impact Case Rep. 2013 Nov 19;1(4):2324709613512622. doi: 10.1177/2324709613512622. eCollection 2013 Oct-Dec.

本文引用的文献

Phenytoin dose adjustment in epileptic patients.癫痫患者的苯妥英钠剂量调整。

Br J Clin Pharmacol. 1974 Apr;1(2):163-8. doi: 10.1111/j.1365-2125.1974.tb00226.x.

Rate of elimination of tracer doses of phenytoin at different steady-state serum phenytoin concentrations in epileptic patients.不同稳态血清苯妥英浓度下癫痫患者示踪剂量苯妥英消除率。

Br J Clin Pharmacol. 1974 Apr;1(2):155-61. doi: 10.1111/j.1365-2125.1974.tb00225.x.

DIPHENYLHYDANTOIN AND PHENOBARBITAL TOXICITY. THE ROLE OF LIVER DISEASE.二苯乙内酰脲和苯巴比妥中毒。肝脏疾病的作用。

Arch Neurol. 1964 Dec;11:649-56. doi: 10.1001/archneur.1964.00460240081011.

DIPHENYLHYDANTOIN METABOLISM, BLOOD LEVELS, AND TOXICITY.二苯乙内酰脲的代谢、血药浓度及毒性

Arch Neurol. 1964 Dec;11:642-8. doi: 10.1001/archneur.1964.00460240074010.

DIAGNOSTICALLY CONFUSING COMPLICATIONS OF DIPHENYLHYDANTOIN THERAPY. A REVIEW.苯妥英治疗的诊断混淆并发症。综述。

Ann Intern Med. 1963 Dec;59:914-30. doi: 10.7326/0003-4819-59-6-914.

Metabolic disposition of diphenylhydantoin in normal human subjects following intravenous administration.静脉注射后苯妥英在正常人体中的代谢情况。

Clin Pharmacol Ther. 1969 Jul-Aug;10(4):498-504. doi: 10.1002/cpt1969104498.

Relationship between the plasma level of diphenylhydantoin sodium and its cardiac antiarrhythmic effects.苯妥英钠血药浓度与其心脏抗心律失常作用的关系。

Circulation. 1968 Aug;38(2):363-74. doi: 10.1161/01.cir.38.2.363.

Value of blood phenytoin estimation in management of childhood epilepsy.血液苯妥英钠测定在儿童癫痫管理中的价值。

Arch Dis Child. 1971 Jun;46(247):386-8. doi: 10.1136/adc.46.247.386.

Diphenylhydantoin intoxication. A complication of isoniazid therapy.二苯妥英中毒。异烟肼治疗的一种并发症。

Am Rev Respir Dis. 1970 Mar;101(3):377-84. doi: 10.1164/arrd.1970.101.3.377.

Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients.苯巴比妥与苯妥英在动物及癫痫患者体内的相互作用。

Ann N Y Acad Sci. 1971 Jul 6;179:88-107. doi: 10.1111/j.1749-6632.1971.tb46892.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验